These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 743383)

  • 21. Bioavailability: some pharmaceutical factors.
    Fowle AS
    Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035
    [No Abstract]   [Full Text] [Related]  

  • 22. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V; Musakhanian J; Marchaud D
    Adv Drug Deliv Rev; 2008 Mar; 60(6):734-46. PubMed ID: 18045728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of the rate of release of phenobarbital from dry galenic forms: the Erweka ZT3 apparatus and the Poole balloon].
    Duru C; Jacob M; Puech A; Slany J
    Pharm Acta Helv; 1981; 56(4-5):137-41. PubMed ID: 7255501
    [No Abstract]   [Full Text] [Related]  

  • 24. French and/or European perspectives on biopharmaceutical characterization of drug dosage forms.
    Aiache JM
    J Pharm Biomed Anal; 1990; 8(6):499-506. PubMed ID: 2093387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro drug release rate as a standard requirement.
    Láng B
    Pharmazie; 1971 Nov; 26(11):661-4. PubMed ID: 5154319
    [No Abstract]   [Full Text] [Related]  

  • 26. Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.
    Gonnissen Y; Verhoeven E; Peeters E; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2008 May; 69(1):320-34. PubMed ID: 18248803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Resotest Apparatus. A universally applicable biopharmaceutical experimental tool.
    Koch HP
    Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):97-102. PubMed ID: 7339334
    [No Abstract]   [Full Text] [Related]  

  • 28. A mini review of scientific and pharmacopeial requirements for the disintegration test.
    Donauer N; Löbenberg R
    Int J Pharm; 2007 Dec; 345(1-2):2-8. PubMed ID: 17935916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of dosage form on drug effect].
    Zathurecký L
    Pharmazie; 1972 Nov; 27(11):686-93. PubMed ID: 4650983
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 31. Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties.
    Foldvari M; Bagonluri M
    Nanomedicine; 2008 Sep; 4(3):173-82. PubMed ID: 18550451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dry coating, a novel coating technology for solid pharmaceutical dosage forms.
    Luo Y; Zhu J; Ma Y; Zhang H
    Int J Pharm; 2008 Jun; 358(1-2):16-22. PubMed ID: 18467045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
    Levy G; Barr WH
    Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential thermal, solubility, and aging studies on various sources of digoxin and digitoxin powder: biopharmaceutical implications.
    Chiou WL; Kyle LE
    J Pharm Sci; 1979 Oct; 68(10):1224-9. PubMed ID: 512850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of biologic availability of active principles contained in galenic forms for cutaneous administration].
    Aiache JM; Aiache S; Guilpain G; Paire M
    Boll Chim Farm; 1977 Feb; 116(2):63-80. PubMed ID: 861080
    [No Abstract]   [Full Text] [Related]  

  • 36. [Topical pharmaceutical forms].
    Zerrouk N; Arnaud P
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S24-6. PubMed ID: 17563710
    [No Abstract]   [Full Text] [Related]  

  • 37. Improving the compaction properties of roller compacted calcium carbonate.
    Bacher C; Olsen PM; Bertelsen P; Kristensen J; Sonnergaard JM
    Int J Pharm; 2007 Sep; 342(1-2):115-23. PubMed ID: 17582712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of preoral sustained-release preparations with a base of biodegradable polymers. 3. Preparation of matrix tablets with a base of poly-3-hydroxybutyric acid].
    Mank R; Kala H; Richter M; Babel W; Sattler K
    Pharmazie; 1989 Aug; 44(8):545-7. PubMed ID: 2594825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of drug metabolism in drug research and development: pharmaceutical chemistry aspects.
    Heimlich KR
    J Pharm Sci; 1972 Oct; 61(10):1686-9. PubMed ID: 5072432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.